HEADER TRANSCRIPTION 26-JAN-05 2BIV TITLE CRYSTAL STRUCTURE OF THE WILD-TYPE MBT DOMAINS OF HUMAN SCML2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SEX COMB ON MIDLEG-LIKE PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: MBT DOMAIN, RESIDUES 1-243; COMPND 5 SYNONYM: SCML2 PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PRSETA; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PRSETA KEYWDS MALIGNANT BRAIN TUMOR, TRANSCRIPTION FACTOR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR C.M.SANTIVERI,M.D.ALLEN,F.SAIT,M.BYCROFT REVDAT 5 13-DEC-23 2BIV 1 REMARK REVDAT 4 24-JAN-18 2BIV 1 SOURCE REVDAT 3 05-FEB-14 2BIV 1 HEADER KEYWDS JRNL REMARK REVDAT 3 2 1 VERSN FORMUL REVDAT 2 24-FEB-09 2BIV 1 VERSN REVDAT 1 08-FEB-05 2BIV 0 JRNL AUTH C.M.SANTIVERI,B.C.LECHTENBERG,M.D.ALLEN,A.SATHYAMURTHY, JRNL AUTH 2 A.M.JAULENT,S.M.V.FREUND,M.BYCROFT JRNL TITL THE MALIGNANT BRAIN TUMOR REPEATS OF HUMAN SCML2 BIND TO JRNL TITL 2 PEPTIDES CONTAINING MONOMETHYLATED LYSINE. JRNL REF J.MOL.BIOL. V. 382 1107 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18706910 JRNL DOI 10.1016/J.JMB.2008.07.081 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 69250 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 3493 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4838 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 631 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.62100 REMARK 3 B22 (A**2) : 0.37200 REMARK 3 B33 (A**2) : 1.24900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.335 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 44.39 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2BIV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-JAN-05. REMARK 100 THE DEPOSITION ID IS D_1290022667. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX10.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 69311 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 19.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.18000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1OI1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.14M SODIUM IODIDE, 20.5% PEG3350, REMARK 280 15MG/ML PROTEIN REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.01000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 93.49400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.10300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 93.49400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.01000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.10300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 GLN A 3 REMARK 465 THR A 4 REMARK 465 VAL A 5 REMARK 465 ASN A 6 REMARK 465 GLU A 7 REMARK 465 ASP A 8 REMARK 465 SER A 9 REMARK 465 MET A 10 REMARK 465 ASP A 11 REMARK 465 VAL A 12 REMARK 465 LYS A 13 REMARK 465 LYS A 14 REMARK 465 GLU A 15 REMARK 465 ASN A 16 REMARK 465 GLN A 17 REMARK 465 GLU A 18 REMARK 465 LYS A 19 REMARK 465 THR A 20 REMARK 465 PRO A 21 REMARK 465 GLN A 22 REMARK 465 SER A 23 REMARK 465 SER A 24 REMARK 465 THR A 25 REMARK 465 SER A 26 REMARK 465 SER A 27 REMARK 465 VAL A 28 REMARK 465 GLN A 29 REMARK 465 ARG A 30 REMARK 465 ASP A 31 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 GLN B 3 REMARK 465 THR B 4 REMARK 465 VAL B 5 REMARK 465 ASN B 6 REMARK 465 GLU B 7 REMARK 465 ASP B 8 REMARK 465 SER B 9 REMARK 465 MET B 10 REMARK 465 ASP B 11 REMARK 465 VAL B 12 REMARK 465 LYS B 13 REMARK 465 LYS B 14 REMARK 465 GLU B 15 REMARK 465 ASN B 16 REMARK 465 GLN B 17 REMARK 465 GLU B 18 REMARK 465 LYS B 19 REMARK 465 THR B 20 REMARK 465 PRO B 21 REMARK 465 GLN B 22 REMARK 465 SER B 23 REMARK 465 SER B 24 REMARK 465 THR B 25 REMARK 465 SER B 26 REMARK 465 TYR B 134 REMARK 465 GLN B 135 REMARK 465 MET B 136 REMARK 465 ASN B 137 REMARK 465 THR B 138 REMARK 465 SER B 139 REMARK 465 MET C 1 REMARK 465 GLY C 2 REMARK 465 GLN C 3 REMARK 465 THR C 4 REMARK 465 VAL C 5 REMARK 465 ASN C 6 REMARK 465 GLU C 7 REMARK 465 ASP C 8 REMARK 465 SER C 9 REMARK 465 MET C 10 REMARK 465 ASP C 11 REMARK 465 VAL C 12 REMARK 465 LYS C 13 REMARK 465 LYS C 14 REMARK 465 GLU C 15 REMARK 465 ASN C 16 REMARK 465 GLN C 17 REMARK 465 GLU C 18 REMARK 465 LYS C 19 REMARK 465 THR C 20 REMARK 465 PRO C 21 REMARK 465 GLN C 22 REMARK 465 SER C 23 REMARK 465 SER C 24 REMARK 465 THR C 25 REMARK 465 SER C 26 REMARK 465 SER C 27 REMARK 465 VAL C 28 REMARK 465 GLN C 29 REMARK 465 ARG C 30 REMARK 465 ASP C 31 REMARK 465 TYR C 134 REMARK 465 GLN C 135 REMARK 465 MET C 136 REMARK 465 ASN C 137 REMARK 465 THR C 138 REMARK 465 SER C 139 REMARK 465 SER C 140 REMARK 465 TRP C 141 REMARK 465 PRO C 142 REMARK 465 MET C 143 REMARK 465 PHE C 144 REMARK 465 LEU C 145 REMARK 465 LEU C 146 REMARK 465 LYS C 147 REMARK 465 THR C 148 REMARK 465 LEU C 149 REMARK 465 ASN C 150 REMARK 465 GLY C 151 REMARK 465 SER C 152 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 76 78.61 -164.36 REMARK 500 ASP A 101 -175.63 -68.37 REMARK 500 THR A 242 34.98 -96.96 REMARK 500 ASN B 76 86.31 -152.40 REMARK 500 SER B 100 -136.32 -99.50 REMARK 500 ASP B 101 -167.01 -125.69 REMARK 500 ASN B 185 70.83 -152.22 REMARK 500 PRO B 186 -32.22 -39.83 REMARK 500 ASN C 76 77.14 -178.04 REMARK 500 ASP C 101 -157.54 -73.98 REMARK 500 ASN C 185 68.24 -156.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD A 1244 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD B 1244 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD B 1245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 1246 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD C 1244 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD C 1245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA C 1247 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD C 1248 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OI1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MBT DOMAINS OF HUMAN SCML2 REMARK 900 RELATED ID: 2VYT RELATED DB: PDB REMARK 900 THE MBT REPEATS OF HUMAN SCML2 BIND TO PEPTIDES CONTAINING MONO REMARK 900 METHYLATED LYSINE. DBREF 2BIV A 1 243 UNP Q9UQR0 SCL2_HUMAN 1 243 DBREF 2BIV B 1 243 UNP Q9UQR0 SCL2_HUMAN 1 243 DBREF 2BIV C 1 243 UNP Q9UQR0 SCL2_HUMAN 1 243 SEQRES 1 A 243 MET GLY GLN THR VAL ASN GLU ASP SER MET ASP VAL LYS SEQRES 2 A 243 LYS GLU ASN GLN GLU LYS THR PRO GLN SER SER THR SER SEQRES 3 A 243 SER VAL GLN ARG ASP ASP PHE HIS TRP GLU GLU TYR LEU SEQRES 4 A 243 LYS GLU THR GLY SER ILE SER ALA PRO SER GLU CYS PHE SEQRES 5 A 243 ARG GLN SER GLN ILE PRO PRO VAL ASN ASP PHE LYS VAL SEQRES 6 A 243 GLY MET LYS LEU GLU ALA ARG ASP PRO ARG ASN ALA THR SEQRES 7 A 243 SER VAL CYS ILE ALA THR VAL ILE GLY ILE THR GLY ALA SEQRES 8 A 243 ARG LEU ARG LEU ARG LEU ASP GLY SER ASP ASN ARG ASN SEQRES 9 A 243 ASP PHE TRP ARG LEU VAL ASP SER PRO ASP ILE GLN PRO SEQRES 10 A 243 VAL GLY THR CYS GLU LYS GLU GLY ASP LEU LEU GLN PRO SEQRES 11 A 243 PRO LEU GLY TYR GLN MET ASN THR SER SER TRP PRO MET SEQRES 12 A 243 PHE LEU LEU LYS THR LEU ASN GLY SER GLU MET ALA SER SEQRES 13 A 243 ALA THR LEU PHE LYS LYS GLU PRO PRO LYS PRO PRO LEU SEQRES 14 A 243 ASN ASN PHE LYS VAL GLY MET LYS LEU GLU ALA ILE ASP SEQRES 15 A 243 LYS LYS ASN PRO TYR LEU ILE CYS PRO ALA THR ILE GLY SEQRES 16 A 243 ASP VAL LYS GLY ASP GLU VAL HIS ILE THR PHE ASP GLY SEQRES 17 A 243 TRP SER GLY ALA PHE ASP TYR TRP CYS LYS TYR ASP SER SEQRES 18 A 243 ARG ASP ILE PHE PRO ALA GLY TRP CYS ARG LEU THR GLY SEQRES 19 A 243 ASP VAL LEU GLN PRO PRO GLY THR SER SEQRES 1 B 243 MET GLY GLN THR VAL ASN GLU ASP SER MET ASP VAL LYS SEQRES 2 B 243 LYS GLU ASN GLN GLU LYS THR PRO GLN SER SER THR SER SEQRES 3 B 243 SER VAL GLN ARG ASP ASP PHE HIS TRP GLU GLU TYR LEU SEQRES 4 B 243 LYS GLU THR GLY SER ILE SER ALA PRO SER GLU CYS PHE SEQRES 5 B 243 ARG GLN SER GLN ILE PRO PRO VAL ASN ASP PHE LYS VAL SEQRES 6 B 243 GLY MET LYS LEU GLU ALA ARG ASP PRO ARG ASN ALA THR SEQRES 7 B 243 SER VAL CYS ILE ALA THR VAL ILE GLY ILE THR GLY ALA SEQRES 8 B 243 ARG LEU ARG LEU ARG LEU ASP GLY SER ASP ASN ARG ASN SEQRES 9 B 243 ASP PHE TRP ARG LEU VAL ASP SER PRO ASP ILE GLN PRO SEQRES 10 B 243 VAL GLY THR CYS GLU LYS GLU GLY ASP LEU LEU GLN PRO SEQRES 11 B 243 PRO LEU GLY TYR GLN MET ASN THR SER SER TRP PRO MET SEQRES 12 B 243 PHE LEU LEU LYS THR LEU ASN GLY SER GLU MET ALA SER SEQRES 13 B 243 ALA THR LEU PHE LYS LYS GLU PRO PRO LYS PRO PRO LEU SEQRES 14 B 243 ASN ASN PHE LYS VAL GLY MET LYS LEU GLU ALA ILE ASP SEQRES 15 B 243 LYS LYS ASN PRO TYR LEU ILE CYS PRO ALA THR ILE GLY SEQRES 16 B 243 ASP VAL LYS GLY ASP GLU VAL HIS ILE THR PHE ASP GLY SEQRES 17 B 243 TRP SER GLY ALA PHE ASP TYR TRP CYS LYS TYR ASP SER SEQRES 18 B 243 ARG ASP ILE PHE PRO ALA GLY TRP CYS ARG LEU THR GLY SEQRES 19 B 243 ASP VAL LEU GLN PRO PRO GLY THR SER SEQRES 1 C 243 MET GLY GLN THR VAL ASN GLU ASP SER MET ASP VAL LYS SEQRES 2 C 243 LYS GLU ASN GLN GLU LYS THR PRO GLN SER SER THR SER SEQRES 3 C 243 SER VAL GLN ARG ASP ASP PHE HIS TRP GLU GLU TYR LEU SEQRES 4 C 243 LYS GLU THR GLY SER ILE SER ALA PRO SER GLU CYS PHE SEQRES 5 C 243 ARG GLN SER GLN ILE PRO PRO VAL ASN ASP PHE LYS VAL SEQRES 6 C 243 GLY MET LYS LEU GLU ALA ARG ASP PRO ARG ASN ALA THR SEQRES 7 C 243 SER VAL CYS ILE ALA THR VAL ILE GLY ILE THR GLY ALA SEQRES 8 C 243 ARG LEU ARG LEU ARG LEU ASP GLY SER ASP ASN ARG ASN SEQRES 9 C 243 ASP PHE TRP ARG LEU VAL ASP SER PRO ASP ILE GLN PRO SEQRES 10 C 243 VAL GLY THR CYS GLU LYS GLU GLY ASP LEU LEU GLN PRO SEQRES 11 C 243 PRO LEU GLY TYR GLN MET ASN THR SER SER TRP PRO MET SEQRES 12 C 243 PHE LEU LEU LYS THR LEU ASN GLY SER GLU MET ALA SER SEQRES 13 C 243 ALA THR LEU PHE LYS LYS GLU PRO PRO LYS PRO PRO LEU SEQRES 14 C 243 ASN ASN PHE LYS VAL GLY MET LYS LEU GLU ALA ILE ASP SEQRES 15 C 243 LYS LYS ASN PRO TYR LEU ILE CYS PRO ALA THR ILE GLY SEQRES 16 C 243 ASP VAL LYS GLY ASP GLU VAL HIS ILE THR PHE ASP GLY SEQRES 17 C 243 TRP SER GLY ALA PHE ASP TYR TRP CYS LYS TYR ASP SER SEQRES 18 C 243 ARG ASP ILE PHE PRO ALA GLY TRP CYS ARG LEU THR GLY SEQRES 19 C 243 ASP VAL LEU GLN PRO PRO GLY THR SER HET IOD A1244 1 HET IOD A1245 1 HET IOD A1246 1 HET IOD B1244 1 HET IOD B1245 1 HET NA B1246 1 HET IOD B1247 1 HET IOD C1244 1 HET IOD C1245 1 HET IOD C1246 1 HET NA C1247 1 HET IOD C1248 1 HETNAM IOD IODIDE ION HETNAM NA SODIUM ION FORMUL 4 IOD 10(I 1-) FORMUL 9 NA 2(NA 1+) FORMUL 16 HOH *631(H2 O) HELIX 1 1 HIS A 34 GLY A 43 1 10 HELIX 2 2 PRO A 48 PHE A 52 5 5 HELIX 3 3 GLY A 119 GLU A 124 1 6 HELIX 4 4 ASN A 137 SER A 139 5 3 HELIX 5 5 SER A 140 ASN A 150 1 11 HELIX 6 6 SER A 156 PHE A 160 5 5 HELIX 7 7 SER A 210 ASP A 214 5 5 HELIX 8 8 GLY A 228 GLY A 234 1 7 HELIX 9 9 HIS B 34 THR B 42 1 9 HELIX 10 10 PRO B 48 PHE B 52 5 5 HELIX 11 11 GLY B 119 GLU B 124 1 6 HELIX 12 12 SER B 140 ASN B 150 1 11 HELIX 13 13 SER B 156 PHE B 160 5 5 HELIX 14 14 GLY B 228 GLY B 234 1 7 HELIX 15 15 HIS C 34 THR C 42 1 9 HELIX 16 16 PRO C 48 PHE C 52 5 5 HELIX 17 17 GLY C 119 GLU C 124 1 6 HELIX 18 18 SER C 156 PHE C 160 5 5 HELIX 19 19 SER C 210 ASP C 214 5 5 HELIX 20 20 GLY C 228 GLY C 234 1 7 SHEET 1 AA 5 PHE A 106 LEU A 109 0 SHEET 2 AA 5 ARG A 92 LEU A 97 -1 O LEU A 93 N ARG A 108 SHEET 3 AA 5 ASN A 76 THR A 89 -1 O THR A 84 N ARG A 96 SHEET 4 AA 5 LYS A 68 ASP A 73 -1 O LEU A 69 N ALA A 83 SHEET 5 AA 5 ILE A 115 GLN A 116 -1 O GLN A 116 N GLU A 70 SHEET 1 AB 5 TYR A 215 LYS A 218 0 SHEET 2 AB 5 GLU A 201 PHE A 206 -1 O VAL A 202 N CYS A 217 SHEET 3 AB 5 ILE A 189 LYS A 198 -1 O THR A 193 N THR A 205 SHEET 4 AB 5 LYS A 177 ILE A 181 -1 O LEU A 178 N ALA A 192 SHEET 5 AB 5 ILE A 224 PHE A 225 -1 O PHE A 225 N GLU A 179 SHEET 1 BA 5 PHE B 106 LEU B 109 0 SHEET 2 BA 5 ARG B 92 LEU B 97 -1 O LEU B 93 N ARG B 108 SHEET 3 BA 5 ASN B 76 THR B 89 -1 O THR B 84 N ARG B 96 SHEET 4 BA 5 LYS B 68 ASP B 73 -1 O LEU B 69 N ALA B 83 SHEET 5 BA 5 ILE B 115 GLN B 116 -1 O GLN B 116 N GLU B 70 SHEET 1 BB 5 TYR B 215 LYS B 218 0 SHEET 2 BB 5 GLU B 201 PHE B 206 -1 O VAL B 202 N CYS B 217 SHEET 3 BB 5 ILE B 189 LYS B 198 -1 O THR B 193 N THR B 205 SHEET 4 BB 5 LYS B 177 ILE B 181 -1 O LEU B 178 N ALA B 192 SHEET 5 BB 5 ILE B 224 PHE B 225 -1 O PHE B 225 N GLU B 179 SHEET 1 CA 5 PHE C 106 LEU C 109 0 SHEET 2 CA 5 ARG C 92 LEU C 97 -1 O LEU C 93 N ARG C 108 SHEET 3 CA 5 ASN C 76 THR C 89 -1 O THR C 84 N ARG C 96 SHEET 4 CA 5 LYS C 68 ASP C 73 -1 O LEU C 69 N ALA C 83 SHEET 5 CA 5 ILE C 115 GLN C 116 -1 O GLN C 116 N GLU C 70 SHEET 1 CB 5 TYR C 215 LYS C 218 0 SHEET 2 CB 5 GLU C 201 PHE C 206 -1 O VAL C 202 N CYS C 217 SHEET 3 CB 5 ILE C 189 LYS C 198 -1 O THR C 193 N THR C 205 SHEET 4 CB 5 LYS C 177 ILE C 181 -1 O LEU C 178 N ALA C 192 SHEET 5 CB 5 ILE C 224 PHE C 225 -1 O PHE C 225 N GLU C 179 SITE 1 AC1 1 TRP A 216 SITE 1 AC2 2 TRP B 35 ARG B 231 SITE 1 AC3 2 HIS B 34 LYS B 162 SITE 1 AC4 1 HOH B2048 SITE 1 AC5 1 TRP B 216 SITE 1 AC6 2 TRP C 107 HOH C2061 SITE 1 AC7 4 TYR B 215 TRP B 216 HOH B2208 HOH C2061 SITE 1 AC8 3 TRP C 35 ARG C 231 HOH C2048 CRYST1 40.020 88.206 186.988 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024988 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011337 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005348 0.00000